Paliperidone controlled-release - Delpor

Drug Profile

Paliperidone controlled-release - Delpor

Alternative Names: DLP-115

Latest Information Update: 16 Aug 2016

Price : $50

At a glance

  • Originator Delpor
  • Class 2 ring heterocyclic compounds; Antipsychotics; Fluorobenzenes; Isoxazoles; Piperidines; Pyrimidinones; Small molecules
  • Mechanism of Action Dopamine D2 receptor antagonists; Serotonin 2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Bipolar disorders; Schizophrenia

Highest Development Phases

  • Research Bipolar disorders; Schizophrenia

Most Recent Events

  • 16 Aug 2016 Chemical structure information added
  • 15 Aug 2016 Early research in Schizophrenia in USA (SC)
  • 15 Aug 2016 Early research in Bipolar disorders in USA (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top